新冠肺炎流行期间医护人员的心理健康状况调查及分析

目的 了解新冠肺炎流行期间医护人员心理健康状况并分析其相关因素.方法 采用自制一般情况调查表、症状自评量表(SCL-90)、社会支持评定量表(SSRS)和简易应对方式量表(SCSQ),对扬州大学附属医院的医护人员进行调查.结果 在新冠肺炎流行期间,医护人员SCL-90各因子分均值与全国常模比较,在躯体化、强迫、抑郁、恐...     

新冠肺炎期间援鄂护理人员的心理健康状况调查与分析

目的 调查分析武汉泰康同济医院某感染科援鄂护理人员的心理健康状况.方法 于2020年2月～4月期间,选取武汉泰康同济医院某感染科60名援鄂护理人员作为研究对象,采用症状自评量表(SCL-90)对其心理进行测评,分析调查结果并提出相应的建议.结果 60名受访的援鄂护理人员中,有55人(91.7％)分数超过160分,出现不...     

新冠肺炎疫情期间武汉市居民心理状况及其影响因素分析

目的:了解新冠肺炎疫情期间武汉市居民的心理应激反应及创伤后成长水平,为后续开展心理干预提供科学参考依据。方法:采用一般资料问卷、突发性公共卫生事件心理问卷、创伤后成长量表对武汉市311名居民进行问卷调查。结果:居民负性情绪总体呈轻中度水平,其抑郁、神经衰弱、恐惧、强迫-焦虑、疑病5个维度的阳性检出率分别为61.10%、69.78%、97.75%、57.23%、45.02%;不同人口学因素对居民负性情绪的不同维度存在影响,其中有无慢性疾病组间所有维度比较差异均有统计学意义(P<0.05)。居民的创伤后成长总得分为(45.59±19.96)分,阳性检出率为96.78%,其中人生领悟维度得分最高。结论:新冠肺炎疫情期间,武汉市居民存在不同程度的心理应激压力,但同时也呈现出一定水平的创伤后成长。提示相关部门应采取一定措施,对负面情绪的高危人群加强正面引导,促进个体创伤后成长。     

新冠肺炎患者心理状态调查及其相关影响因素分析

目的 探讨新冠肺炎患者心理状态及其相关影响因素.方法 选择2020年2月19日至3月30日支援武汉期间接诊的新冠肺炎患者78例,分析新冠肺炎患者心理状态及其相关影响因素.结果 78例患者Zung焦虑自评量表(SAS)评分为(54.41±6.58)分,其中筛查出焦虑51例(65.38％),包括重度焦虑6例(11.76％)...     

住院患者新冠肺炎认知和焦虑情况的调查及管理对策

目的 了解新冠肺炎疫情下住院患者对新冠肺炎的认知、态度、应对行为及焦虑状况,做好疫情期间的患者管理.方法 对2020年3月15-30日在佛山市第一人民医院禅城医院住院的117例患者进行问卷调查,内容包括人口学特征、认知情况、应对行为和焦虑自评量表(SAS).结果 不同年龄、学历的住院患者新冠肺炎认知、态度和相关行为改变...     

新冠肺炎患者总病程及影响因素分析

目的 研究影响新冠肺炎总病程长短的因素.方法 收集2020年1-3月收治的70例新冠肺炎患者的临床资料,对其性别、年龄、从感染到发病时间、住院时间、发病前2周内是否规范使用抗病毒药物治疗及治疗种类、病程中最低淋巴细胞计数、最高C反应蛋白、病程中核酸检测阳性的次数、是否合并其他基础疾病等进行分析,对上述影响因素进行单因素...     

线上药学服务对15例新型冠状病毒肺炎轻型和普通型患者心理状况的影响

目的探讨线上药学服务对新型冠状病毒肺炎(COVID-19)轻型和普通型患者心理状况和用药依从性的影响。方法选取四川省成都市某COVID-19市级定点收治医院2020年1月23日至2月14日收治的COVID-19轻型和普通型患者15例,采用焦虑自评量表(SAS)、抑郁自评量表(SDS)、Morisky用药依从性量表-4(MMSA-4)评估患者接受线上药学服务前后心理状况和用药依从性的变化。结果接受线上药学服务7 d后,患者的SAS和SDS评分均较干预前显著降低(P <0.05);MMSA-4评分均为0~2分,依从性好,但与接受药学服务前比较无显著差异(P> 0.05)。结论线上药学服务可缓解COVID-19轻型和普通型患者的焦虑和抑郁情绪。     

Shedding the light on Pharmacists’ roles during COVID-19 global pandemic

Introduction(Background)The role of pharmacists revolves around providing the highest levels of care to society and ensuring the provision of medicine to all patients. However, with the spread of coronavirus disease 2019 (COVID −19), pharmacists as a very important part of healthcare professionals’ team are responsible for fighting against the disease regardless of their setting of practice. The role of pharmacists will undergo a little change to extend and include other roles in order to ensure the safety of the community and limit the virus spread. Also, they will be required to obtain information from reliable sources, and to be up to date, so they can be reliable advisors to the community and raise their awareness.ObjectivesThe purpose of this review is to highlight community and hospital pharmacists’ roles during (COVID-19) global pandemic, and to clearly illustrate how they are contributing to maintain pharmacy services continuity, supporting other healthcare professionals, and facilitating the patient’s education.SummaryClinical pharmacists provide direct patient care through monitoring adverse drug reactions, ensuring individualized treatment, performing evidence-based practice, and evaluating drugs in clinical trials. On the other hand, community pharmacists which are the most accessible healthcare providers by the community increase their awareness regarding the preventive measures, balance medicines supply and demand, provide drive-thru and home delivery services, offer telehealth counselling, psychological support, refer suspected COVID-19 patients, and provide vaccination when available.ConclusionInnovative pharmacists’ roles have emerged to adapt to changes during COVID-19 pandemic, however, they may be needed in the post COVID-19 world as well.     

Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study

BackgroundTo enable services to be provided at a distance during the COVID-19 pandemic, outpatient pharmacy services in Australia underwent near-immediate reform by moving to telehealth, including telephone and video consults.ObjectiveTo investigate how telehealth was used in a metropolitan outpatient pharmacy setting before and after the start of the COVID-19 restrictions and the various influences on the uptake of phone and video modalities.MethodsA multi-methods approach was used including: (1) quantifying administrative activity data between July 2019 to December 2020 and, (2) semi-structured interviews with key stakeholders (n = 34).ResultsActivity data: Between July 2019 to December 2020 16,377 outpatient pharmacy consults were provided. Of these, 13,543 (83%) were provided in-person, 2,608 (16%) by telephone and 226 (1.4%) by video consult. COVID-19 impacted how these services were provided with telephone activity more than four-times higher in April 2020 than March 2020 and slight increases in video consults. Pharmacists have heavily favoured using the telephone despite the recommendation that video consults be used as the primary mode of contact and that telephone only be used when a video consult was not possible. As soon as COVID-19 restrictions eased, clinicians gradually returned to in-person appointments, maintaining some use of telephone and very limited use of video consult. Semi-structured interviews: Whilst clinicians recognised the potential benefits of video consults, challenges to routine use included the additional administrative and planning work required pre-consult, perceptions that patients were unable to use the technology, and the belief that in-person care was ‘better’ and that the telephone was easier.ConclusionOrganisational strategies that encouraged the use of video over telephone (e.g. through financial incentives) did not appear to influence clinicians’ choice of care modality. Implementation studies are required to co-develop solutions to embed telehealth options into outpatient pharmacy settings that provide the best experience for both patients and clinicians.     

新冠肺炎疫情期间武汉市三级定点医院药学服务调研及分析

目的:研究新型冠状病毒肺炎疫情期间武汉市19家三级定点医院药学服务开展情况,分析疫情期间药学服务内容及存在的问题,提出医院药学发展建议.方法:通过在线填写问卷的方式,对武汉市19家三级定点医院药学服务进行调查,搜集在新型冠状病毒肺炎疫情防控期间各医院运行的基本资料,统计分析药品供应与调剂、药师岗位调动、临床药学服务、药...     

Community Pharmacists: On the frontline of health service against COVID-19 in LMICs

The COVID-19 outbreak is a global public health crisis which has affected healthcare practice across professions. In the context of this pandemic, there is a need to highlight the roles and responsibilities of pharmacists. Community pharmacists are the most accessible healthcare professionals to the general public and have a lot to offer amid the COVID-19 response. This have led to significant changes in the health systems of many countries. This article seeks to highlight additional roles and activities relating to the public health response that can be undertaken by community pharmacists that could help to reduce pressure on general practice and other areas of the health service.     

新冠肺炎疫情期间发热门诊处方分析

目的：了解新冠肺炎疫情期间，发热门诊新型冠状病毒肺炎疑似患者的药物治疗情况。方法：通过电子处方系统，导出发热门诊新型冠状病毒肺炎疑似患者的所有处方，用SPSS进行统计分析。结果：2020年1月5日至2020年2月23日，发热门诊疑似患者3 549例，其中男性为1 661例（46.8%），平均年龄为48±15.1岁，高发年龄段为40~60岁，1 482例（41.8%）。2020年1月22日至2月8日，最高日处方数达到764张。所有患者均给予了抗病毒和抗感染治疗。13 645张处方，含有抗病毒药物的处方有7 174张（52.6%），其中单用抗病毒西药为阿比朵尔1 491（20.8%），更昔洛韦1 962（27.3%），中成药为连花清瘟或金叶败毒1 578（22.0%），中西联用处方有阿比朵尔+（莲花清瘟或金叶败毒）1 397（19.5%）和更昔洛韦注射液+（莲花清瘟或金叶败毒）299（4.2%）；含有抗感染治疗的处方有6 781（49.7%）张，主要药物为莫西沙星，6 118（90.2%）。其中有349（10.1%）位患者使用了糖皮质激素治疗，且男性偏多。449（12.6%）名患者进行了免疫疗法。结论：发热门诊新冠肺炎疑似患者的药物治疗基本按流感病毒，中东呼吸综合征（MERS）和严重急性呼吸综合征（SARS）的治疗经验进行早期的抗病毒，抗感染，营养支持及对症治疗等方式进行，对于重症患者使用了糖皮质激素治疗和免疫疗法。     

新冠肺炎不同疫情阶段下某院门诊药房应急预案的持续改进

目的 根据新型冠状病毒肺炎疫情形势的改变,持续改进应急预案来加强门诊药房的防控工作.方法 分析不同疫情阶段下的本地和外部形势,结合最新的诊疗和防控等指导文件实时改进门诊药房应急预案,从人员、服务、环境、物资、学习等五方面实施方案,并定期对具体实施效果进行评价.结果 我市1月24日启动重大突发公共卫生事件一级响应后我院门...     

COVID-19普通型患者药物治疗管理模式的建立与实践

目的 梳理总结药师在COVID-19普通型患者药物治疗管理过程中的作用,为疫情特殊时期的医院药学工作提供参考。方法 根据实际工作情况,结合文献查阅,阐述COVID-19疫情防控时期临床药师为普通型患者提供药物治疗管理的具体实践和探索。结果 临床药师积极参与COVID-19普通型患者的诊治医疗活动,展开药物治疗管理,充分做好药物治疗分析,及时识别各类药物不良反应、药物相互作用等,参与多学科协作诊疗讨论,提供药物信息,为患者提供科学、合理和个体化的给药方案。结论 面对突发疫情事件,临床药师充分利用信息系统,及时调整药学工作应对策略,发挥药学特长,保障患者安全合理用药。     

新型冠状病毒疫苗相关的皮肤不良反应分析

目的探讨巢湖市接种新型冠状病毒疫苗(新冠疫苗)后皮肤不良反应( CADRs)的发生情况。方法选取 2021年 1― 12月在安徽医科大学附属巢湖医院就诊的接种新冠疫苗后发生 CADRs病人 270例,并对其临床资料进行统计分析。结果 270例 CADRs病人中男 112例( 41.48%)女 158例( 58.52%)年龄范围为 4~90岁,年龄( 44.04±21.41)岁; CADRs发生时间主要集中在新冠疫苗接种后7d内(216例,8,0.0%); CADRs类型,主要包括荨麻疹( 85例, 31.48%)、接种部位局部红肿( 80例,29.63%)、非特异性皮疹( 78例, 28.89%)等;根据药物不良反应关联度评价,将皮疹表现类型分为很可能、可能及不明确三种,其中很可能的皮疹( 80例, 29.63%)、可能( 177例, 65.56%)、不明确( 13例, 4.81%)。根据引起皮肤不良反应的疫苗种类分为灭活疫苗( 142例, 52.60%)、重组疫苗( 128例, 47.40%);引起 CADRs的新冠疫苗接种剂次以第 1剂次居多( 178例, 65.92%)。结论接种新冠疫苗后发生的 CADRs中,以接种灭活疫苗多见,第 1剂次居多,多见于中年女性,临床症状以荨麻疹表现最常见。所有病人经有效治疗均痊愈,且不遗留后遗症。应正确看待疫苗接种引起的 CADRs,鼓励全员积极接种疫苗,共筑免疫屏障。     

新型冠状病毒肺炎疫情期间药品供应保障实践与相关问题探讨

目的：总结当前新型冠状病毒感染肺炎（COVID-19）疫情下医院药品供应保障实践，为突发公共卫生事件应急药品供应保障提供参考。方法：针对COVID-19期间医院应急药品供应保障的特点、应对措施、难点等方面进行阐述与探讨。结果：COVID-19目前处于防控关键时期，突发公共卫生事件的发生考验医院药事应急管理能力，有效的药品应急保障对医疗救治保障和疫情防控工作发挥重要的作用。结论：本文总结分析医院应急药品供应保障实践工作，为突发公共卫生事件应急药品供应保障管理提供思路。